Impact News +++ Hive Digital expands BUZZ HPC with new cluster in Quebec, acquires Toronto facility to fuel growth (Proactive Investors) +++ HIVE DIGITAL Aktie -3,44%

OVID THERAPEUTICS Aktie

>OVID THERA Aktienkurs

0.258 EUR +3.2% (Tradegate)

Ask: 0.264 EUR / 22800 Stück

Bid: 0.246 EUR / 24500 Stück

Tagesumsatz: 9698 Stück

Realtime Kurs von 8 bis 22 Uhr!

OVID THERA Aktie über LYNX handeln

Intraday

1 Jahr

>OVID THERA Performance

1 Woche: -1,9%

1 Monat: +2,8%

3 Monate: -36,9%

6 Monate: -71,8%

1 Jahr: -65,4%

laufendes Jahr: -71,8%

>OVID THERAPEUTICS Aktie

Name:

OVID THERAPEUTICS DL-,001

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US6904691010 / A2DQ8S

Symbol/ Ticker:

1OT (Frankfurt) / OVID (NASDAQ)

Kürzel:

FRA:1OT, ETR:1OT, 1OT:GR, NASDAQ:OVID

Index:

Webseite:

https://ovidrx.com/

Marktkapitalisierung:

17.88 Mio. EUR

Umsatz:

0.47 Mio. EUR

EBITDA:

-45.8 Mio. EUR

Gewinn je Aktie:

-0.26 EUR

Schulden:

12.49 Mio. EUR

Liquide Mittel:

37.23 Mio. EUR

Umsatz-/ Gewinnwachstum:

-12.2% / -

KGV/ KGV lG:

- / -

KUV/ KBV/ PEG:

35.18 / 0.33 / -

Gewinnm./ Eigenkapitalr.:

- / -36.31%

Dividende je Aktie:

Dividendenrendite/ -schätzung:

- / -

Insiderhandel:

Suchwörter:

OVID THERAPEUTICS, OVID THERAPEUTIC, OVID THERA

Letzte Datenerhebung:

24.06.25

>OVID THERA Eigentümer

Aktien: 71.11 Mio. St.

f.h. Aktien: 50.35 Mio. St.

Insider Eigner: 16.31%

Instit. Eigner: 55.97%

Leerverk. Aktien: 2.34%

>OVID THERA Peer Group

ACHIEVE LIFE

ACURX

ADVERUM

ANSELL ADR

CHAMPIONS ONCOLOGY

COCRYSTAL

ELEDON

ORASURE

SENSEONICS

SONIDA

>OVID THERA Chart & Kurs - NASDAQ

>OVID THERA News

05.06.25 - 13:33	Ovid Therapeutics to Host Investor and Media Event Thursday, June 12, 2025 (GlobeNewswire EN)
	Emerging Biomarkers in the Clinical Development of Epilepsy Medicines and OV329 Program Highlights Emerging Biomarkers in the Clinical Development of Epilepsy Medicines and OV329 Program Highlights...

13.05.25 - 14:18	Ovid Therapeutics GAAP EPS of -$0.14 in-line, revenue of $0.13M beats by $0.1M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

06.05.25 - 17:15	Ovid Therapeutics (OVID) May Report Negative Earnings: Know the Trend Ahead of Q1 Release (Zacks)
	Ovid Therapeutics (OVID) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....

11.03.25 - 15:45	Ovid Therapeutics (OVID) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
	Ovid Therapeutics (OVID) delivered earnings and revenue surprises of 18.75% and 45.71%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?...

11.03.25 - 13:18	Ovid Therapeutics GAAP EPS of -$0.13 beats by $0.03, revenue of $0.07M misses by $0.12M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

03.03.25 - 14:03	Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos to Board of Directors (GlobeNewswire EN)
	NEW YORK, March 03, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to developing small-molecule medicines for brain conditions with significant unmet need, today announced the appointment of Stelios Papadopoulos, Ph.D. to its Board of Directors....

01.03.25 - 00:01	Insiderhandel: President and COO verkauft Aktien von Ovid Therapeutics im Wert von 2956 USD (Insiderkauf)
	Alexander, Margaret A. - Vorstand - Tag der Transaktion: 2025-02-26...

01.03.25 - 00:01	Insiderhandel: CBFO verkauft Aktien von Ovid Therapeutics im Wert von 2185 USD (Insiderkauf)
	Rona, Jeffrey A. - Vorstand - Tag der Transaktion: 2025-02-26...

27.02.25 - 14:03

Ovid Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference (GlobeNewswire EN)

NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to developing medicines for brain conditions with significant unmet need, today announced that Meg Alexander, President and Chief Operating Officer, will present at the TD Cowen 45th Annual Health Care Conference on Monday, March 3, 2025, at 3:10 p.m. ET in Boston, Massachusetts....

05.02.25 - 14:03	Ovid Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference (GlobeNewswire EN)
	NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to developing medicines for brain conditions with significant unmet need, today announced that management will participate in a virtual presentation at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on Wednesday, February 12, 2025, at 4:00 p.m. ET....

29.01.25 - 16:01	Insiderhandel: President and COO kauft Aktien von Ovid Therapeutics im Wert von 4971 USD (Insiderkauf)
	Alexander, Margaret A. - Vorstand - Tag der Transaktion: 2025-01-27...

12.11.24 - 16:33	Ovid Therapeutics (OVID) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
	Ovid Therapeutics (OVID) delivered earnings and revenue surprises of -5.26% and 15.33%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?...

12.11.24 - 14:57	Ovid Therapeutics GAAP EPS of -$0.20 misses by $0.01, revenue of $0.17M beats by $0.1M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

11.09.24 - 14:09

Meg Alexander Takes on Expanded Role as President and COO at Ovid Therapeutics, Strengthening Leadership for Future Growth (GlobeNewswire EN)

NEW YORK, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to improving the lives of people affected by rare epilepsies and brain conditions, today announced the promotion of Meg Alexander to President and Chief Operating Officer (COO). Alexander will work in collaboration with Ovid's leadership team to advance Ovid's development pipeline of potential disease-halting neurotherapeutics and define and execute its go-forward strategy....

04.09.24 - 14:06	Ovid Therapeutics to Present at Upcoming September Investor Conferences (GlobeNewswire EN)
	NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to improving the lives of people affected by rare epilepsies and brain conditions, today announced that management will participate in two upcoming investor conferences in September:...

20.08.24 - 19:33	Ovid Therapeutics (OVID) Upgraded to Buy: Here′s Why (Zacks)
	Ovid Therapeutics (OVID) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy)....

13.08.24 - 16:33	Ovid Therapeutics (OVID) Q2 Earnings and Revenues Surpass Estimates (Zacks)
	Ovid Therapeutics (OVID) delivered earnings and revenue surprises of 154.55% and 20.71%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?...

13.08.24 - 15:40	Ovid Therapeutics Inc reports results for the quarter ended in June - Earnings Summary (Reuters EN)
	Ovid Therapeutics Inc reports results for the quarter ended in June - Earnings Summary...

13.08.24 - 15:06	Ovid Therapeutics GAAP EPS of $0.12, revenue of $0.17M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

13.08.24 - 14:03	Ovid Therapeutics Reports Business Updates and Second Quarter 2024 Financial Results (GlobeNewswire EN)
	NEW YORK, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to improving the lives of people affected by rare epilepsies and brain conditions, today reported business updates and financial results for the second quarter ended June 30, 2024....

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Wer das Recht mit Füßen tritt, steht selten fest auf den Beinen. - Stanislaw Jerzy Lec

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram